清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

The rhPTH (1–34), But not Elcatonin, Increases Bone Anabolic Efficacy in Postmenopausal Women with Osteoporosis

内科学 医学 内分泌学 骨重建 骨质疏松症 骨吸收 合成代谢 人口 N-末端末端肽 骨矿物 碱性磷酸酶 化学 骨钙素 生物化学 环境卫生 酶
作者
L. Zhang,Mengliu Yang,D. Liu,C. Guo,L. Li,Gangyi Yang
出处
期刊:Experimental and Clinical Endocrinology & Diabetes [Thieme Medical Publishers (Germany)]
卷期号:120 (06): 361-366 被引量:7
标识
DOI:10.1055/s-0032-1309009
摘要

PURPOSE: Intermittent administration of recombinant human PTH [rhPTH (1-34)] exerts an osteoanabolic effect characterized by direct effects on bone formation, increases bone density, and reduces fracture risk. This study was to investigate the anabolic effects of rhPTH(1-34) on postmenopausal osteoporosis in an Asian population and compare the time course and alteration in bone turnover marker (BTM) during rhPTH(1-34) and elcatonin treatment. METHODS: 124 women with postmenopausal osteoporosis were enrolled in this prospective, open-label, active-controlled trial. The patients randomized to subcutaneous rhPTH(1-34) (20 ug, once daily) or elcatonin (200U, once week) injections for 12 months. Biochemical markers of bone formation (bone specific alkaline phosphatase [BSAP]), and bone resorption maker (serum C-telopeptide of type I collagen [CTX-I] were measured at baseline and at 0, 6, and 12 months. RESULTS: At 12 months, rhPTH (1-34) significantly increased lumbar spine BMD significantly compared with baseline, whereas elcatonin was ineffective. BSAP levels were gradually increased in almost all rhPTH(1-34)-treated subjects and at the end of the study, the percentage of subjects with BSAP above the postmenopausal reference interval was gradually increased as high as 91.5% at month 12. Opposite trends in percentages for CTX-I was observed in rhPTH(1-34). With rhPTH(1-34), but not elcatonin, there were significant positive correlations between ratio of BSAP and CTX-I and bone mineral density (BMD) (r=0.318) at the end of month 12. Both treatments were well tolerated and there were no significant differences detected between the 2 groups in the proportion of any adverse events and any serious adverse events. CONCLUSIONS: rhPTH (1-34) has more positive effects on bone formation than elcatonin for postmenopausal women with osteoporosis and was proved to be safe and well tolerated. The ratio of BSAP and CTX-I may be a useful indicator for positive bone formation.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
205完成签到,获得积分10
2秒前
卡卡完成签到,获得积分10
2秒前
聪明的羿完成签到,获得积分10
2秒前
2秒前
顺心凝阳完成签到,获得积分10
3秒前
shiluodeqiou完成签到,获得积分10
4秒前
白昼完成签到,获得积分10
5秒前
ZHZ完成签到,获得积分10
5秒前
321987杰完成签到 ,获得积分10
7秒前
内向的镜子完成签到,获得积分10
7秒前
MaidLingYan完成签到,获得积分10
7秒前
huan完成签到,获得积分10
10秒前
ssnwlp123完成签到,获得积分10
10秒前
BlueLe完成签到,获得积分10
11秒前
Zilaap完成签到,获得积分10
12秒前
CaptainMus完成签到,获得积分10
13秒前
端庄的如松完成签到,获得积分10
13秒前
皮卡皮卡皮卡丘完成签到,获得积分10
14秒前
Maestro_S的应助被科研通管家采纳,获得10
15秒前
null的应助被科研通管家采纳,获得10
16秒前
花开富贵完成签到,获得积分10
17秒前
luyu完成签到,获得积分10
17秒前
mayberichard完成签到,获得积分10
17秒前
热情善斓完成签到,获得积分10
18秒前
dianeil发布了新的文献求助10
18秒前
hh完成签到,获得积分10
20秒前
昊儿虫完成签到,获得积分10
20秒前
宝哥完成签到,获得积分10
20秒前
顺心雁开完成签到,获得积分10
23秒前
Cling5899完成签到,获得积分10
24秒前
bao完成签到,获得积分10
25秒前
小冯完成签到,获得积分10
29秒前
fomo完成签到,获得积分0
30秒前
坦率钢笔完成签到,获得积分10
31秒前
yuan完成签到,获得积分10
32秒前
精明开山完成签到,获得积分10
35秒前
刘沂卓完成签到,获得积分10
37秒前
suda完成签到,获得积分10
41秒前
怡然的千儿完成签到,获得积分10
44秒前
MIO完成签到,获得积分10
46秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185411
求助须知:如何正确求助?哪些是违规求助? 9574140
关于积分的说明 21834375
捐赠科研通 7782865
什么是DOI,文献DOI怎么找? 3434552
关于科研通互助平台的介绍 2558842
邀请新用户注册赠送积分活动 2481280